BeiGene Ltd ADR buy Guggenheim
Start price
28.02.23
/
50%
€214.00
Target price
28.02.24
€329.84
Performance (%)
-26.17%
End price
29.02.24
€158.00
Summary
This prediction ended on 29.02.24 with a price of €158.00. The prediction for BeiGene Ltd ADR disappointed with a performance of -26.17%. Guggenheim has a follow-up prediction for BeiGene Ltd ADR where he still thinks BeiGene Ltd ADR is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BeiGene Ltd ADR | 0.000% | 0.000% | -3.333% |
iShares Core DAX® | 4.097% | 1.280% | 17.609% |
iShares Nasdaq 100 | 5.110% | -0.741% | 32.406% |
iShares Nikkei 225® | 5.333% | -0.280% | 16.646% |
iShares S&P 500 | 3.487% | -0.006% | 27.373% |
Comments by Guggenheim for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $350.00 price target on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten